16 April 2020

Marc Spaanderman has been appointed Professor of Obstetrics at Radboud University/ Radboud university medical center, with effect from 1 March 2020. Prior to his arrival in Nijmegen, Spaanderman was professor and head of the Department of Obstetrics and Gynaecology at Maastricht University/Maastricht UMC+.
Marc Spaanderman (1966, Waldbauer) completed his Master's degree in Medicine at Utrecht University in 1993. He then specialised in gynaecology and obstetrics at Maastricht University, where he earned his PhD in 2001 for research into changes in cardiovascular and renal function in women before and during pregnancy. In addition to healthy women, he examined many women who had suffered from pre-eclampsia, a common cardiovascular disease during pregnancy.

Spaanderman has worked as a researcher and gynaecologist at Maastricht UMC+, the Maxima Medical Centre and Radboud university medical center. In 2012, he was appointed professor in Maastricht. His research interests include preconception counselling, high-risk pregnancy, maternal physiology, gender-sensitive cardiovascular disease and health and health education. Prevention of cardiovascular disease is the central theme in his research.

At Radboud university medical center, Prof. Spaanderman will dedicate himself to building a care and research expertise network within the scientific theme Vascular damage. That network will focus on women with an increased risk of cardiovascular dysfunction with the aim of improving and maintaining health before, during and after pregnancy. Spaanderman will also remain associated with Maastricht UMC+ as a professor and will explicitly strive for intensive and overarching cooperation between the two centres.

Related news items

Technology saves lives! 1.9 million euros from the Heart Foundation for developing smart watches

17 November 2021

Niels van Royen is proud to be part of this consortium, initiated by Judith Bonnes, to develop a wrist band for early detection of cardiac arrest. Together with Erasmus, Reinier de Graaf and Corsano Health.

read more

Turbo Grants for four medical-technical research projects

19 October 2021

Four TURBO grants were recently awarded to new technical-medical research proposals. The grants are part of the TURBO program, a collaboration between the University of Twente (TechMed Centre) and the Radboudumc.

read more

COVID-19 associated coagulopathy - lessons after 1 year

17 May 2021

Jenneke Leentjens, Saskia Middeldorp, and colleagues, published a review on the current knowledge of COVID-19 associated coagulopathy and the role of antithrombotic therapies in the Lancet Haematology.

read more

Royal decorations for Nicoline Hoogerbrugge, Jolanda de Vries, Koos van der Velden and Jan Buitelaar

28 April 2021

Nicoline Hoogerbrugge, Jolanda de Vries, Koos van der Velden and Jan Buitelaar are appointed by His Majesty as Knight in the Order of the Dutch Lion, a highly prestigious decoration on 26 April 2021.

read more

2.5 million Euros for cancer research into ovarian cancer and immunotherapy

15 April 2021

The Radboudumc receives 2.5 million Euros from the Dutch Cancer Society (KWF) for three studies to ensure oncological progress during COVID-19 period.

read more

Transfer of new anti-hepatitis C drugs across the human placenta

9 September 2020

In a recent publication in American Journal of Obstetrics and Gynecology, researchers from the Departments of Pharmacology and Toxicology, Pharmacy, Obstetrics and Gynecology, Gastroenterology and Hepatology, investigated the placental passage of two such drugs for the first time.

read more